Research Topics
| Kim M FoxSummaryAffiliation: Royal Brompton Hospital Country: UK Publications
| Collaborators
|
Detail Information
Publications
Selective and specific I(f) inhibition: new perspectives for the treatment of stable anginaKim Fox
Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK
Expert Opin Pharmacother 7:1211-20. 2006..It offers clear therapeutic benefits for a whole range of patients with stable angina, including those with contraindications or intolerance to beta-blockers...
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)K M Fox
Cardiology Department, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Lancet 362:782-8. 2003..We assessed whether the ACE inhibitor perindopril reduced cardiovascular risk in a low-risk population with stable coronary heart disease and no apparent heart failure...
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable anginaKim M Fox
Royal Brompton and Harefield NHS Trust, London, UK
Eur Heart J 24:2206-12. 2003..The aim of this study was to evaluate whether sildenafil, used for treatment of erectile dysfunction (ED), affects the exercise tolerance and ischaemic threshold in men with exercise-induced angina not taking nitrates...
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery diseaseKim M Fox
Cardiology Department, Royal Brompton Hospital, Sydney Street, London, UK
Am Heart J 153:629-35. 2007....
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]Kim Fox
Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Kardiol Pol 64:823-80. 2006
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyKim Fox
Department of Cardiology, Royal Brompton Hospital, London, UK
Eur Heart J 27:1341-81. 2006
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable anginaCaroline Daly
Royal Brompton and Harefield NHS Trust, Royal Brompton Hospital, Sydney Street, and London School of Hygiene and Tropical Medicine, SW3 6NP, UK
Eur Heart J 27:1298-304. 2006..This study focuses on the impact of guideline compliant medical treatment on clinical outcome in patients with stable angina...
The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable AnginaCaroline A Daly
Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK
Eur Heart J 26:996-1010. 2005....
Gender differences in the management and clinical outcome of stable anginaCaroline Daly
Royal Brompton Hospital, Sydney St, London SW3 6 NP, UK
Circulation 113:490-8. 2006..We sought to examine the impact of gender on the investigation and subsequent management of stable angina and to assess gender differences in clinical outcome at 1 year...
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational studyCaroline A Daly
Royal Brompton Hospital, London SW3 6NP
BMJ 332:262-7. 2006..To investigate the prognosis associated with stable angina in a contemporary population as seen in clinical practice, to identify the key prognostic features, and from this to construct a simple score to assist risk prediction...
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudyCaroline A Daly
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Eur Heart J 26:1369-78. 2005....
Heart rate: a forgotten link in coronary artery disease?Kim M Fox
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Nat Rev Cardiol 8:369-79. 2011..Effective heart rate control among patients with coronary artery disease is uncommon in clinical practice, representing a missed therapeutic opportunity...
The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of StabCaroline A Daly
Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Eur Heart J 26:1011-22. 2005....
Under-diagnosis of diabetes mellitus in patients with coronary artery diseaseNeville Kukreja
Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Int J Cardiol 97:77-82. 2004..The uptake of medical treatment in patients with coronary artery disease may be suboptimal. Our intention was to review the medical treatment of these patients in the light of current evidence...
[Universal definition of the myocardial infarction.]Kristian Thygesen
Department of Medicine and Cardiology, Aarhus University Hospital, Dania
Kardiol Pol 66:47-62. 2008
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trialRoberto Ferrari
Chair of Cardiology, University of Ferrara, Arcispedale S Anna, Corso Giovecca 203, 44100, Ferrara, Italy
Expert Rev Cardiovasc Ther 5:1037-46. 2007..Data on the pathophysiological mechanisms underlying CAD indicate direct vascular protection with perindopril. This helps explain why perindopril is beneficial in preventing cardiac events in stable CAD patients...
Universal definition of myocardial infarctionKristian Thygesen
Circulation 116:2634-53. 2007
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study)Gaston A Rodriguez Granillo
Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Am J Cardiol 100:159-63. 2007....
Cardiovascular diseases in women: a statement from the policy conference of the European Society of CardiologyMarco Stramba-Badiale
Eur Heart J 27:994-1005. 2006..We also propose some immediate actions that should be undertaken with the hope that synergic activities will be implemented at European level with the support of national health care authorities...
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trialWitold Ruzyllo
Department of Coronary Artery Disease and Cardiac Catheterization Laboratory, Institute of Cardiology, Warsaw, Poland
Drugs 67:393-405. 2007..This study was undertaken to compare the antianginal and anti-ischaemic effects of the novel heart-rate-lowering agent ivabradine and of the calcium channel antagonist amlodipine...
Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular functionMichel E Bertrand
Lille Heart Institute, Lille, France
Int J Cardiol 121:57-61. 2007..The EUROPA trial has demonstrated that an ACE inhibitor perindopril, was able to significantly decrease the risk of major cardiac events in patients with stable coronary heart disease without apparent heart failure...
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENTClaudio Ceconi
University of Ferrara and Cardiovascular Pathophysiology Research Centre, Salvatore Maugeri Foundation, IRCCS, Gussago Brescia, Italy
Cardiovasc Res 73:237-46. 2007..Our objective was to study the effect of perindopril on endothelial function and to verify its link to risk and occurrence of cardiovascular events...
Silent myocardial ischemiaPeter F Cohn
State University of New York Health Sciences Center, Stony Brook, NY 11794-8171, USA
Circulation 108:1263-77. 2003
The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stentingPing Li
Cardiovascular Department, Second Affiliated Hospital of Jiangxi Medical College, Nanchang 330006, China
Chin Med J (Engl) 118:1525-32. 2005..The objective of this study was to examine the effect of this variation on the occurrence of restenosis after in-stent treatment in patients with coronary artery disease...
